Enrofloxacin + Ketoconazole + Triamcinolone + Silver Sulfadazine + Tobramycin + Polymixin B
14 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
14
Total Reports
0
Deaths Reported
0.0%
Death Rate
Active Ingredients
Enrofloxacin + Ketoconazole + Triamcinolone + Silver Sulfadazine + Tobramycin + Polymixin B
Administration Routes
Auricular (Otic)Unknown
Species Affected
Dog 13
Cat 1
Most Affected Breeds
Retriever - Labrador 3
Spaniel - Cocker American 2
Retriever - Golden 1
Rottweiler 1
Schnauzer (unspecified) 1
Spitz - German Pomeranian 1
Chihuahua 1
Domestic Shorthair 1
Bulldog 1
Hound - Basset 1
Most Reported Reactions
Lack of efficacy - NOS 4
Emesis 3
Weight loss 3
Vomiting 3
INEFFECTIVE, HEARTWORM LARVAE 2
Leucocytosis NOS 2
Not eating 2
Immune mediated haemolytic anaemia 2
Splenomegaly 2
Elevated serum alkaline phosphatase (SAP) 2
Decreased activity 2
Otitis externa 2
Outcome Breakdown
Outcome Unknown
6 (42.9%)
Ongoing
5 (35.7%)
Recovered/Normal
3 (21.4%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.